reported normal muscle histology in obligate carriers demonstrating the phenomenon of lyonization with a large variability of Xchromosome inactivation in Mb-precursor cells. Thus. carrier detection by muscle biopsy is only reliable in cases with pathologic muscle histology. whereas canier exclusion is not practicable in any case.
The gene for X-linked centronuclear myopathy was recently localized by linkage analysis to the chromosome region Xq28
(1 1 -16). The determination of closely linked informative DNA markers as F8. p767, St 14. cpX67. and DX 13 has resulted in improved camer detection and has opened the possibility of firsttrimester prenatal diagnosis. Combination of physical mapping and linkage analysis data leads to the most probable marker order R / G C P -G~P D -( X L R -C N M -F~) -P~~~-S~ 14-cpX67-DX 13, placing the XLR-CNM gene close to F8 ( 1 6).
We present here the results of four prenatal diagnoses in three XLR-CNM families by the use of RFLP.
MATERIALS A N D M E T H O D S
Fumilies. In family 1 (Fig. 1.4) . two prenatal diagnoses have been performed at 9 and I0 wk of gestation for an obligate carrier (03) having had two affected sons and one spontaneous abortion of a male fetus. In previous generations. nine males had died from asphyxia. proving an X-linked pattern of inheritance.
The patient of family 2 ( Fig. IB) was the first child of a healthy unrelated couple with a negative family history of XLR-CNM. The mother's (03) carrier state was not known. and she asked for prenatal diagnosis at 10 wk of gestation. The pedigree of family 3 (Fig. IC) shows the patient to be a sporadic case. as in family 2. His mother (03) exhibits a slight muscle weakness. but the histopathologic evaluation of the muscle biopsy did not reveal any morphologic changes suspected of centronuclear myopathy.
Muscle biopsy was not available from the mother (03) of family 2 to evaluate the carrier state. Risk ca1culation.s. There is no information about gene frequency and mutation rate in XLR-CNM families. But in Xlinked recessive lethal diseases. in which no affected male has a chance to reproduce and. assuming equal mutation rates in eggs and sperm, the risk of a patient to be a sporadic case bearing a new mutation is thought to be one third (17) . In the absence of any other information, a risk of one in three (33%) would be given for a male fetus to be affected. Allowing for germline mosaicism, using the estimated recurrence risk B of 7% of DMD families (1 8). the risk of the fetus being affected would be ?/3 X ' /z (carrier) + B x '/3 (mosaic) ( 1 9). For the mothers in family 2 and 3, the a priori recurrence risk has been calculated to be 36%.
The obligate carrier in family I has an u priori risk of 50% for transmitting the XLR-CNM gene. DNA anu1jw.s. DNA was extracted from peripheral-blood lymphocytes and from chorionic villi obtained from the at-risk fetuses using standard methods (20) . Two and one half pg of DNA were digested with the appropriate restriction endonucleases (Boehringer, Mannheim, Germany) under the conditions suggested by the manufacturer. Southern blot analyses and probe hybridization were performed by previously described methods (21) . The families had been typed before with the probes St 14(DXS52), DX 13(DXS 1 5), pC(F8C), p767(DSX 1 1 9 , and cpX67(DXS134) from the Xq28 region (16) . The source of the probes, restriction enzymes, allele sizes, and order of the loci have previously been described (16) . The following probes were informative and used for prenatal diagnosis: St14 and DX13 in family I ; St 14 plus an additional marker St35-69 1 (DXS305) detecting RFLP with the restriction enzymes PstI (allele 1 5. I kb/ allele 2 2.9, 2.2kb) and TaqI (allele 1 4.4kb/allele 2 4.0kb) in family 2; and St 14, cpX67 and St35-69 1 in family 3.
RESULTS
The first prenatal diagnosis performed in family I using the markers St 14 and DX 13 demonstrated the XLR-CNM-associated haplotype in the male fetus, indicating a high risk of being affected. The mother decided to terminate the pregnancy, which was done at 1 1 wk of gestation, but unfortunately, no fetal tissue became available at pregnancy termination. The linkage analysis of the second prenatal diagnosis 10 mo later detected again the maternal XLR-CNM haplotype, but in a female fetus, predicting a healthy girl (Fig. 1A) . In March 1990, the mother gave birth to her first unaffected child after five pregnancies.
In family 2, the mother was informative for the two DNA markers St14 and St35-691. Prenatal diagnosis at 10 wk of gestation showed the same marker-allele constellation in the male fetus as in the affected boy (Fig. I B) , increasing the risk of being affected to 38%. The couple elected to continue the pregnancy, because the woman's carrier state was not defined. In December 1989, the mother delivered an affected boy, who died 2 d after birth. proving her to be a carrier or a germline mosaic (with a probability of about 5%). Tracing back the mutation origin in this family, we found the two patients carrying the haplotype of their grandfather.
Family 3 represents approximately the same situation as does XLR-CNM PRENATAL DIAGNOSIS 203 family 2: one affected boy (isolated case). unknown carrier state of the mother. and a male fetus with the same grandmaternal XLR-CNM-linked haplotype as his deceased brother (Fig. I C' ). The pregnancy was terminated at 13 wk ofgestation. and skeletal muscle of the fetus was analyzed by optical microscopy (semithin sections of Epon 8 I '-embedded tissue: Fig. 20 and h) , histochemistry. and clectron microscopy ( Fig. 2.) . The maturation state of the muscle corresponded to a fetal age of 13 wk (22) . By histochemistry (ATPase. oxidative enzymes). there was a uniform enzyme reaction without a clear-cut subdivision into fiber types and no reciprocal reaction between oxidative enzymes on the one hand and ATPase on the other. Most of the cells detectable by electron microscopy were Mb as apparent single cells containing closely aggregated bundles of myofilaments forming z-bands or grouped with others in "early myotubes" surrounded by a basement membrane. Fb and other mesenchymal cells lacked showing greater diameters and intensively stained homogeneous degenerated myofibrils in the periphery of the fibers. Staining: methylene blueazure. ~3 1 . 5 . basement membrane and myofilaments and had extensive. welldeveloped rough endoplasmic reticulum and multiple elongated cytoplasmic extensions. However, multinucleated "later myotubes" were also identified. demonstrating a homogeneous destruction of their myofibrils (Fig. 2~) .
Longitudinal sections of myotubes
The central regions of these myotubes contain large nuclei with frequently prominent nucleoli, many mitochondria, glycogen particles, and sometimes "myelin figures," probably derived from degenerating mitochondria (Fig. 2c) . In contrast to the general ultrastructural appearances of normal skeletal muscle from human fetuses of 10-14 wk gestational age, nearly no satellite cells (separated from the underlying myotube but enclosed by the same common basement membrane) were observed. These morphologic findings indicate the prenatal manifestation of the disease and lead to the interpretation of the mother being a carrier or a germline mosaic (probability = 5%).
DISCUSSION
Before the localization of the XLR-CNM gene and the availability of DNA markers linked to the disease, prenatal diagnosis had not been possible. We recently presented linkage analyses data of eight XLR-CNM families confirming close linkage of the XLR-CNM gene to the region Xq28 (16) . We report here on the first four prenatal diagnoses of XLR-CNM using the recommended DNA markers of the Xq28 region. The analyses of one female and three male fetuses revealed maternal transmission of the XLR-CNM-associated alleles in all four cases, indicating a carrier state for the girl, an affected status for the boy of family 1, and a risk of 38% to be affected for the fetuses of families 2 and 3. Two of the male fetuses have been aborted. and the pregnancies of the third male and the female fetuses have been continued. The diagnosis of XLR-CNM at the birth of the third boy, as well as the pathologic findings in the muscle of one of the aborted fetuses confirmed the linkage results of the prenatal analyses. Our findings prove the DNA markers St14. cpX67. DX 13, and pSt35-69 1 to be useful in prenatal diagnosis of XLR-CNM and present the possibility of confirming the diagnosis by histologic examination of the first-trimester abortus. This means an important progress for the families at risk compared with the previous situation, where no prenatal diagnosis was available. However, the histologic analysis of fetal skeletal muscle does not present prenatal diagnosis itself, but enables checking of the DNA results. As long as one is using linkage-based indirect analyses. the counseling of families is more complex because one is dealing with probabilities of an affected or unaffected fetus. rather than with a definitive diagnosis based on direct observation, especially in families with sporadic cases. Prenatal diagnosis will not be possible in families in which the mother is uninformative or material of key persons is missing or when recombination events are found. Moreover, the probability of germinal mosaicism should be taken into account in calculation of carrier risks for females belonging to families with X-linked recessive lethal diseases. That means a boy can be affected because his mother is a carrier or a germline mosaic, or because he is a new mutation.
St 14 and DX 13 showed highest linkage (lod-scores = 3.60 and 2.02) at a genetic distance of 5% recombination, with the most probable marker order being XLR-CNM-St 14-cpX67-DX 13 (16) . No recombination events were observed in the three families tested. leading to the estimated accuracy of the prediction of about 95%. The use of flanking markers. not yet available for XLR-CNM. would significantly reduce the uncertainty of the counseling situation. Further analyses are under investigation to define closely linked flanking markers and to isolate the gene itself.
